1E Therapeutics vs Deep Genomics
1E Therapeutics vs Deep Genomics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: 1E Therapeutics is on 48/100 and Deep Genomics on 61/100.
Where each one leads
1E Therapeutics
Leads on none of the measures we hold for both companies.
Deep Genomics
- our overall score: 61/100 against 48/100
- domain rating: 54/100 against 20/100
- headcount: 110 against 49
- funding raised: $241M against $120M
- LinkedIn following: 30,891 against 3,258
At a glance
| Measure | 1E Therapeutics | Deep Genomics |
|---|---|---|
| What it is | Drug development company creating first-in-class RNA-targeting therapeutics using a proprietary platform. | AI-powered biotechnology company developing RNA therapeutics for genetic diseases. |
| Category | Drug Development, Life Sciences, Therapeutics, RNA-Targeting | Biotech, Drug Discovery, Genomics, AI-Driven Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2020 | 2015 |
| Headquarters | Not published | Toronto, Canada |
| Status | Active | Active |
Size, funding and growth
| Measure | 1E Therapeutics | Deep Genomics |
|---|---|---|
| Employees | 49 | 110 |
| Headcount growthLast 12 months | +18.6% | +19.3% |
| Total funding | $120M | $241M |
| Latest round | Seed | Series C |
| LinkedIn followers | 3,258 | 30,891 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | 1E Therapeutics | Deep Genomics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 48/100 | 61/100 |
| Traction | 57/100 | 60/100 |
| Team | 50/100 | 60/100 |
| Search visibility | 39/100 | 33/100 |
| Quality | 45/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 54/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | 1E Therapeutics | Deep Genomics |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Not detected | Google Analytics 4, Segment |
1E Therapeutics vs Deep Genomics: common questions
Which is better, 1E Therapeutics or Deep Genomics?
On our 0-100 score Deep Genomics rates higher (61/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do 1E Therapeutics and Deep Genomics compare on the numbers?
Deep Genomics leads on our overall score (61/100 against 48/100), domain rating (54/100 against 20/100), headcount (110 against 49), funding raised ($241M against $120M), LinkedIn following (30,891 against 3,258).
Read the full 1E Therapeutics review and pricing or the Deep Genomics review and pricing. You can also browse other 1E Therapeutics alternatives we track.